Two novel cervical cancer treatment approaches show progress: the CRAIN trial has completed dose-finding for tolinapant, an apoptosis inhibitor, while ICMR develops the SHetA2 pill for precancerous lesions.
Faron Pharmaceuticals announces acceptance of bexmarilimab Phase I/II data for poster presentation at BSH 2026, while launching a new Phase II BEAM-X study evaluating the drug in AML patients post-stem cell transplantation.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07751133 |
Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer |
NOT_YET_RECRUITING | PHASE3 |
| NCT07516054 |
Action Falls for Domiciliary Care |
RECRUITING | |
| NCT07470437 |
The Mouth Matters in Mental Health Trial -2 |
RECRUITING | NA |
| NCT07252206 |
A Case Series of Culturally-adapted CBTp for Black People in the UK |
RECRUITING | NA |
| NCT06876506 |
Identification of B Regulatory Cells by Flow Cytometry |
NOT_YET_RECRUITING | |
| NCT06559501 |
Integrated Case Management for Burns Care in Pakistan |
ACTIVE_NOT_RECRUITING | NA |
| NCT06368310 |
FIH Clinical Investigation of Graphene Electrodes for Brain Mapping |
COMPLETED | NA |
| NCT05887271 |
A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction |
COMPLETED | PHASE2/PHASE3 |
| NCT05722886 |
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol |
RECRUITING | PHASE2/PHASE3 |
| NCT05425043 |
Granulocyte Transfusions After Umbilical Cord Blood Transplant |
ACTIVE_NOT_RECRUITING | NA |
